NSE is currently the most reliable tumor marker in diagnosis, prognosis, and follow-up of small cell lung cancer as the level of NSE correlates with tumor burden, conditions of metastasis, and treatment response (38). This evidence concerns the gene ENO2 and small cell lung carcinoma.